bioRxiv

CAR T cells targeting inflammatory bone marrow progenitors restore cognition in aged mice

Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.

Paper by Alexander S. Harris, James A. Rouse, 郭广冉, +11 more authorsCorina Amor · Cold Spring Harbor Laboratory · Howard Hughes Medical Institute
Figure 1. Intrathecal uPAR CAR T cells improve and prevent cognitive decline in aging and Tauopathy.
Open the figure at full size
Figure 1. Intrathecal uPAR CAR T cells improve and prevent cognitive decline in aging and Tauopathy.Intrathecal uPAR CAR T cells improve and prevent cognitive decline in aging and Tauopathy.Harris et al.
Studied:
Preprint: experiments in mice
In the record:
One of 40 papers on CAR-T cell therapy on record: 4 with results in people, 1 in animals.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In aged mice and mouse models of Alzheimer's disease, researchers tested CAR T cell therapies targeting inflammatory border-associated macrophages and their bone marrow progenitors. Eliminating border-associated macrophages intrathecally restored cognitive performance. The authors discovered that aged bone marrow myeloid progenitors carry an inflammatory transcriptional state that passes to brain border-associated macrophages to drive neuroinflammation. Targeting these inflammatory progenitors using intravenous CAR T cells reduced neuroinflammation and cognitive impairment, even though the CAR T cells did not infiltrate the brain. Transplanting CAR T-treated progenitors conferred similar benefits. The team found that this proinflammatory progenitor profile is characterized by distinct cell-surface proteins and is conserved in human aging.

Why it matters

The findings show that age-related neuroinflammation and cognitive decline can be modulated remotely by targeting myeloid precursors in the bone marrow. This reveals a peripheral therapeutic target for managing brain aging without needing drugs or cells to enter the brain.

Caveats

The functional experiments were conducted exclusively in mouse models, and the paper is a preprint that has not yet completed peer review.

From the paper

Limitation

While our data shows that elimination of uPAR⁺ BAMs reduces neuroinflammation, non-cell autonomous mechanisms whereby uPAR⁺ BAMs interact with other brain resident cell types (such as microglia, astrocytes and infiltrating immune cells) to collectively sustain neuroinflammation remain unexplored.

Limitations of the study

Quoted word for word from the full text on bioRxiv.

Comments

Be the first to comment.